Validation of a French Quality of Life Questionnaire Adapted to Persons Who Have Suffered a Stroke (QUALI STROKE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02855970|
Recruitment Status : Completed
First Posted : August 4, 2016
Last Update Posted : August 4, 2016
The aim of this work is to develop and validate a scale adapted to French cultural characteristics. It will be based on the SS-QoL scale and be simple and quick to use in everyday practice. It is not simply a translation. This transcultural adaptation requires linguistic and psychometric validation, by studying its validity, its reliability and its sensitivity to change, as though it were a new instrument. The investigators will then develop a short version by reducing the items and conduct a psychometric validation.
The translation and validation of a short French version of the SS-QoL scale will generate a reliable and sensitive, easy-to-use tool suitable for use in everyday practice.
The final objective is to use this tool as a principal judgement criterion in future therapeutic trials and in patients of the Dijon Stroke Registry to bring to light prognostic factors that affect quality of life so as to provide better management of this disease.
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Other: completion of a quality of life questionnaire||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||61 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Development and Validation of a French Quality Of Life Scale Specific to Patients Who Have Suffered a Stroke|
|Study Start Date :||February 2015|
|Actual Primary Completion Date :||August 2015|
Other: completion of a quality of life questionnaire
- responses to a quality of life questionnaire [ Time Frame: Change compared with baseline score at Day 15, Day 60 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02855970
|Centre Hospitalier Universitaire|
|Dijon, France, 21079|